Skip to main content
CellaVision AB (publ) (STO:CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
123.00
-3.40 (-2.69%)
Apr 29, 2026, 12:06 PM CET

CellaVision AB Revenue

CellaVision AB had revenue of 166.43M SEK in the quarter ending March 31, 2026, a decrease of -14.57%. This brings the company's revenue in the last twelve months to 730.59M, down -2.32% year-over-year. In the year 2025, CellaVision AB had annual revenue of 758.97M with 4.94% growth.

Revenue (ttm)
730.59M
Revenue Growth
-2.32%
P/S Ratio
4.13
Revenue / Employee
3.16M
Employees
231
Market Cap
3.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025758.97M35.75M4.94%
Dec 31, 2024723.22M45.93M6.78%
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BICO Group AB 1.50B
Paxman AB 323.56M
MedCap AB 2.11B
Sedana Medical AB 196.15M
C-Rad AB 441.90M
Xvivo Perfusion AB 834.53M
Senzime AB 103.76M
Bactiguard Holding AB 201.18M
Revenue Rankings

CellaVision AB News

More News